$11.18
0.211.91%
At close: -
$11.18
0.000.00%
After Hours: Jun 6, 4:00 PM EDT
Comments
Loading...
Core Laboratories Stock Guidance | NYSE:CLB | Benzinga
Core Laboratories issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/23/2025 | CLB | Core Laboratories | Q2 | 2025 | $0.17 | $0.21 | $0.19 | $128.00M | $134.00M | $128.93M | Get Alert |
| 01/29/2025 | CLB | Core Laboratories | Q1 | 2025 | $0.12 | $0.16 | $0.21 | $121.00M | $127.00M | $131.68M | Get Alert |
| 10/23/2024 | CLB | Core Laboratories | Q4 | 2024 | $0.20 | $0.25 | $0.26 | $128.50M | $135.50M | $136.89M | Get Alert |
| 07/24/2024 | CLB | Core Laboratories | Q3 | 2024 | $0.23 | $0.27 | $0.25 | $131.00M | $137.00M | $135.11M | Get Alert |
| 04/24/2024 | CLB | Core Laboratories | Q2 | 2024 | $0.19 | $0.23 | $0.21 | $130.00M | $136.00M | $130.09M | Get Alert |
| 01/31/2024 | CLB | Core Laboratories | Q1 | 2024 | $0.14 | $0.18 | $0.19 | $122.00M | $128.00M | $127.02M | Get Alert |
| 11/01/2023 | CLB | Core Laboratories | Q4 | 2023 | $0.17 | $0.23 | $0.23 | $125.00M | $132.00M | $132.15M | Get Alert |
| 07/26/2023 | CLB | Core Laboratories | Q3 | 2023 | $0.21 | $0.25 | $0.23 | $128.00M | $132.00M | $135.99M | Get Alert |
| 04/26/2023 | CLB | Core Laboratories | Q2 | 2023 | $0.20 | $0.24 | $0.21 | $130.00M | $135.00M | $132.83M | Get Alert |
| 02/01/2023 | CLB | Core Laboratories | Q1 | 2023 | $0.14 | $0.19 | $0.17 | $125.00M | $129.00M | $126.88M | Get Alert |
| 10/26/2022 | CLB | Core Laboratories | Q4 | 2022 | $0.17 | $0.21 | $0.17 | $126.00M | $131.00M | $129.98M | Get Alert |
| 07/27/2022 | CLB | Core Laboratories | Q3 | 2022 | $0.13 | $0.18 | $0.20 | $123.00M | $129.00M | $125.12M | Get Alert |
| 04/27/2022 | CLB | Core Laboratories | Q2 | 2022 | $0.12 | $0.16 | $0.13 | $119.00M | $125.00M | $114.33M | Get Alert |
| 03/16/2022 | CLB | Core Laboratories | Q1 | 2022 | $0.05 | $0.08 | $0.20 | $110.00M | $113.00M | $110.23M | Get Alert |
| 02/02/2022 | CLB | Core Laboratories | Q1 | 2022 | $0.16 | $0.20 | $0.17 | — | — | — | Get Alert |
| 10/27/2021 | CLB | Core Laboratories | Q4 | 2021 | $0.18 | $0.22 | $0.19 | — | — | — | Get Alert |
| 07/28/2021 | CLB | Core Laboratories | Q3 | 2021 | $0.19 | $0.21 | $0.23 | $122.00M | $126.00M | $125.67M | Get Alert |
FAQ
What is the most recent guidance for Core Laboratories (CLB)?
The most recent guidance for Core Laboratories (CLB) was reported on April 23, 2025 for Q2 2025. The company provided earnings per share guidance in the range of $0.17 to $0.21, compared to the estimated EPS of $0.19. Additionally, Core Laboratories forecasted revenue between $0.13B and $0.13B for the quarter.
Browse guidance and forecast on all stocks.
